Two studies concern the simultaneous use of aromatase inhibitors and vitamins B12 and D. Individual studies indicate the possibility of using known drugs used in other types of cancer and also in the treatment of estrogen-dependent breast cancer. The gene discussed is CYP19A1; the disease is cancer.